rabbits, in doses pathogenic for normal animals. Consequently, in the absence of the damage which B. pneumosintes induces in unprotected rabbit lungs, these vaccinated animals, after intratracheal injection with living B. pneumosintes, were found to be as a rule as resistant as normal rabbits to secondary infection with pneumococcus, streptococcus, and B. pfeijJeri under conditions in which control rabbits were affected. This resistance to infection with ordinary bacteria was maintained also during the period immediately following a single injection of killed B. pneumosintes five times the usual dose. Thus no evidence indicative of a so called "negative phase" was obtained. Attention is directed to these observations because of the association of pulmonary injury due to B. pneumosintes with secondary invasions of the damaged lung by ordinary bacteria which parallels so nearly the relation of epidemic influenza to secondary pneumonic infections in human beings.
The conclusion stated was that "the mildness of the local reactions and the absence of general signs [in rabbits], following vaccination with Bacterium pneumosintes, indicate that similar injections would be well tolerated in man."
In view of the specific protection afforded to rabbits and the absence of any defect in resistance to other infections as a result of subcutaneous vaccination with Bacterium pneumosintes, and having in mind the possible relationship of epidemic influenza to this microorganism, a group of fourteen volunteers at the Army Medical School in Washington, D. C., indicated their desire to submit to the vaccination. Nine of these persons had never had epidemic influenza. Four had suffered from the disease in 1918-19 and one in 1920.
These volunteers were accordingly given three graded doses of heat-killed cultures of Bacterium pneumosintes, and three of them were given a fourth and larger dose. Blood specimens were obtained before and after vaccination for comparison in agglutination tests. Leucocyte counts were also made before, and daily for 3 days after each injection, and the local and general reactions following each dose were noted. The small size of the group was compensated for by the opportunity to study the reactions of each person in detail.
Preparation of Vaccine.
Our observations indicated the cultural and antigenic identity of our strains of B. pneumosintes, whether derived from the epidemic waves of 1918-19, or 1920 , or the recurrence of 1922. As in the instance of the vaccination carried out in the rabbit series, we again used two strains in preparing the vaccine; Strain 17, from the nasopharyngeal secretions of a patient attacked during the 1918-19 epidemic, and Strain 34, from similar secretions obtained during the 1922 recurrence of influenza. The organisms were grown in large quantities in B. coll broth, 5 prepared by adding 10 cc. of a 24 hour broth culture of B. coli to 1 liter of 1 per cent dextrose broth in a Florence flask and incubating for 1 to 2 hours at 37 0 C., or until the faintest visible haze of growth appeared in the clear medium. The medium was then heated in an Arnold steamer at 100 0 C. for 30 minutes under a petrolatum seal. The rapidly cooled broth, now sterile and anaerobic, was then seeded with 2 cc. of the respective cultures of B. pneumosintes grown in Smith-Noguchi medium. After 3 to 5 days incubation, heavy growths were obtained, which were centrifuged, washed with distilled water, and resuspended in salt solution as a stock vaccine. This was heated for 30 minutes at 55-56°C. and standardized by an opacity method.
6 It was then preserved with 0.35 per cent triple distilled cresol and before use it was diluted to correspond to a staphylococcus equivalent s of 2,000 million and 3,000 million organisms per cubic centimeter. After aerobic and anaerobic tests for viability and contamination proved negative, the vaccine was ready for use.
Dosage.
Of the fourteen volunteers (ten enlisted men and four officers) thirteen were studied as described below. The remaining man received only the first two injections and could not be further observed. A first dose of 0.5 cc. (1,000 million) and second and third doses of 1 cc. (2,000 million) were given. Three men received in addition a fourth dose of 1 cc. (3,000 million). All of the doses were estimated on the staphylococcus scale.
The interval between the first and second injections was 5 days (exceptions: 4 days in one instance and 8 in another) and between the second and third injections 8 days (exceptions: 7 days in three instances and 4 days in a fourth). In the three instances in which a fourth dose was given, the interval between the third and fourth doses was 10 days.
Reactions.
The first dose of 1,000 million was well tolerated. In only three instances were slight constitutional disturbances such as headache, mild depression, and generalized pains experienced. One of these 6 Olitsky, P. K., and Gates, F. L., J. Exp. Med., 1922, xxxv, 813. 6 Gates, F. L., J. Exp. Med., 1920, xxxi, 105. men had slight chilly sensations also. The symptoms were transitory, beginning 8 to 10 hours after injection and lasting for a few hours only. All of the men had some tenderness and redness over an area 6 to 8 cm. in diameter at the site of injection, without any induration, as a rule. The local reaction subsided after 2 to 3 days. No one was even temporarily incapacitated.
The second dose of 2,000 million was equally well borne. Again three men reported the general symptoms already mentioned. In no instance did the temperature rise above 99°F. (37.2°C.). Locally, the effects of the reaction were somewhat more severe, for induration was evident in areas 1 to 2 cm. in diameter, which persisted for 7 to 8 days. None of the volunteers was kept from their daily routine.
No constitutional reactions were experienced after the third dose of 2,000 million. The local reactions were similar to those following the second injection.
Finally, in view of the mildness of the reaction with the doses employed, three persons submitted to a fourth dose of 3,000 million, given 10 days after the third inoculation. The vaccine was injected at 10 a.m. At 8 p.m. on the same day one of the three showed a temperature of 99 0 F. (37.2°C.), but did not complain of any constitutional symptoms. The next morning the temperature was normal. However, there developed locally over an area 4 cm. in diameter some redness and induration attended with little or no tenderness. During the night the second man complained of headache, dryness of mouth and lips, and some weakness. The temperature was 99.4°F. (37.4 0 C.). By the next morning the temperature was normal and the constitutional symptoms had disappeared. The site of inoculation was tender and slightly indurated and the area of redness covered one-half of the posterior aspect of the upper arm. At 8.30 p.m. on the day of inoculation the third person showed a temperature of 100°F. (37.8°C.) and complained of dryness of the throat and slight pains in the muscles of the legs. By morning these symptoms had disappeared. Locally there was a red and tender area, without induration, measuring 5 to 6 cm. None of these three was incapacitated for duty by the injection. It may therefore be stated that the injection of doses of killed Bacterium pneumosintes, equivalent in amount to 3,000 million staphylococci, induces a milder reaction than that usually noted with the second or third dose of triple typhoid vaccine.
Effect on the Blood Count.
Leucocyte counts were made on nine of the vaccinated men before, and for 3 consecutive days after each injection. In each instance a rise in the total counts occurred, which carried the average for the nine men to 124, 134, and 143 per cent of its normal value, as shown in Text- fig. 1 . In the chart the mononuclear cells have been plotted separately to show the differences in their behavior, especially after the first and second injections, as compared with the total counts. It is interesting to note that, after the first and second injections, in spite of a rise in the total count which was part of the general reaction, the mononuclear cells suffered an absolute decrease. On the following day their recovery was disproportionately rapid and restored the normal ratio between them and the total count. The leucocytosis was transient and the totals fell again between the 2nd and 3rd days following injection.
At the time of the third injection the average count of the mononuclear cells was found to be high, and it rose to a new level during the following 24 hours, to fall again somewhat the next day. Two sets of final figures are given in the chart. On that day the counts of two of the men were recorded as 16,600 cells per c. mm., 4,000 cells more than any other count on that day and respectively 8,600 and 3,800 cells more than the corresponding figures for the day before. We have no explanation for these sudden and unexpected changes, for they were not accompanied by any observable clinical signs. With these two exceptions the counts throughout the series were fairly uniform, so that the average figures give a reliable picture of the general effects. If these exceptional figures are included, they shift the average counts to the points marked 1 on the chart. If excluded, the averages of the remaining counts fall at the points marked 2.
Production of Agglutinins.
The doses of vaccine given to the rabbits were relatively much larger than those administered to the men. They were followed by the appearance of specific agglutinins in the blood of the rabbits?3 Agglutinins have also been demonstrated in the serum of seventeen of nineteen persons who had recently recovered from epidemic influenza. 7 In the present case of the vaccinated men tests for agglutinins were carried out by the method already described.
7
An examination prior to vaccination of the blood serum of the men was made in dilutions of 1: 2 to 1: 10. No agglutinins against either of the strains of Bacterium pneumosintes used in the vaccine were found present. A second specimen was obtained from twelve of the vaccinated men on the 10th day, and from the other man on the 11th day after the third injection. The results of the agglutination tests with these sera are recorded in Table I .
An examination of the table shows that the blood of eleven of the thirteen vaccinated persons contained agglutinins against the two strains of Bacterium pneumosintes in serum dilutions of 1:4 to 1:40. In the serum of two, no agglutinins were detected. It is, of course, possible that agglutinins might have been found in the blood of these 7 Olitsky, P. K., and Gates, F. L., J. Exp. Med., 1923, xxxvii, 303. men had more specimens been studied. Such variations in antibody response are, of course, known for other organisms. 8 ' 9 In view of the mildness of the reactions in this preliminary series, and the harmlessness of the injections, Lieutenant-Colonel Craig has offered the pneumosintes vaccine to a much larger group of men at Fort Meyer, who have availed themselves of the opportunity. Should there be a recurrence of epidemic influenza in the near future, the efficacy of the vaccination may receive a practical test.
8 Maverick, A., J. Am. Med. Assn., 1912 , lviii, 1672 . Trowbridge, E. H., Finkle, B. A., and Barnard, E. M., J. Am. Med. Assn., 1915 , xiv, 728. 9 Gates, F. L., J. Exp. Med., 1918 
